Beta-Hydroxybutyrate 21FS
Diagnosis and monitoring of Diabetic Ketoacidosis (DKA)
Key Facts
About Vidan Diagnostics
Vidan Diagnostics is an early-stage, private diagnostics company targeting the urgent need for improved Diabetic Ketoacidosis (DKA) management. Its core asset is the Beta-Hydroxybutyrate 21FS test, which measures blood levels of beta-hydroxybutyrate (BHB), the primary ketone body in DKA, offering a more specific and reliable diagnostic marker than traditional methods. The company is likely in a pre-revenue, development stage, aiming to commercialize a product that could enable faster diagnosis, better treatment guidance, and reduced healthcare costs in emergency and point-of-care settings. Success will depend on securing regulatory clearance, demonstrating clinical utility, and navigating a competitive landscape with established and emerging ketone testing solutions.
View full company profile